Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, C. E. Masse, Wenyan Miao et al.|Journal of Medicinal Chemistry|2023Cited by 60
Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)Jun Li, Joseph A. Tino, Hao Zhang et al.|Journal of Medicinal Chemistry|2010Cited by 41
Design, synthesis and structure–activity relationships of azole acids as novel, potent dual PPAR α/γ agonistsHao Zhang, Peter T. W. Cheng, Denis E. Ryono et al.|Bioorganic & Medicinal Chemistry Letters|2009Cited by 35
Comparative Metabolism of Radiolabeled Muraglitazar in Animals and Humans by Quantitative and Qualitative Metabolite ProfilingDonglu Zhang, W. Griffith Humphreys, Lifei Wang et al.|Drug Metabolism and Disposition|2006Cited by 31
Synthesis and structure–activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARα selective activators- PPARα and PPARγ selectivity modulationXiang‐Yang Ye, Joseph A. Tino, Stephanie Chen et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 10